| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
NeuroOne Medical Tech (NASDAQ:NMTC) reported its Q1 earnings results on Tuesday, February 13, 2024 at 04:00 PM.
Here's what investors need to know about the announcement.
NeuroOne Medical Tech reported in-line EPS of $-0.14 versus an estimate of $-0.14.
Revenue was up $863 thousand from the same period last year.
Last quarter the company beat on EPS by $0.04 which was followed by a 11.05% drop in the share price the next day.
Here's a look at NeuroOne Medical Tech's past performance:
| Quarter | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.17 | -0.2 | -0.20 | -0.11 |
| EPS Actual | -0.13 | -0.2 | -0.21 | -0.11 |
| Revenue Estimate | 800K | 350K | 250K | 1.90M |
| Revenue Actual | 741K | 629K | 466K | 114K |
To track all earnings releases for NeuroOne Medical Tech visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: NMTC
